Effects of Intermittent Pneumatic Compression on Recovery of Cyclists

July 29, 2025 updated by: Filipe Silvano Pinto Maia, University of Maia

Effects of Intermittent Pneumatic Compression on the Recovery of High-level Cyclists

This study aims to assess the recovery kinetics of road cyclists following a fatigue protocol (30 time trial).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Portugal
      • Maia, Portugal
        • Universidade da Maia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Road cyclists competing nationally

Exclusion Criteria:

  • Injured athletes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IPC
Intermittent pneumatic compression treatment (30 min peristaltic protocol, at 200mmHg)
Other: recovery
Fatigue protocol
Placebo Comparator: Placebo
A hydrant cream will be used as a placebo
Other: recovery
Fatigue protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle soreness
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Muscle soreness will be assessed using the likert scale of muscle soreness (ranging from 0 to 6)
Baseline, post 30 minutes, post 24 hours, and post 48 hours
Creatine Kinase
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Creatine kinase will be assessed
Baseline, post 30 minutes, post 24 hours, and post 48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low frequency fatigue - Myocece Powerdex score
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Low frequency fatigue will be assessed using Myocene
Baseline, post 30 minutes, post 24 hours, and post 48 hours
4 min time trial
Time Frame: 24 hours post intervention
A 4 minute time trial will be conducted at the 24th hour post-intervention.
24 hours post intervention
Isometric knee extension srength
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Isometric Knee extension exercise will be assessed
Baseline, post 30 minutes, post 24 hours, and post 48 hours
Percieved fatigue
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Likert scale of percieved fatigue (ranging from 0 to 10)
Baseline, post 30 minutes, post 24 hours, and post 48 hours
Sleep questionnaires (consensus sleep diary)
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Sleep quality and quantity will be assessed using a questionnaire, based on the consensus sleep diary
Baseline, post 30 minutes, post 24 hours, and post 48 hours
Perceived recovery
Time Frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours
Total quality recovery scale will be used
Baseline, post 30 minutes, post 24 hours, and post 48 hours
Nutritional diaries
Time Frame: Baseline, post 24 hours, and post 48 hours
Participants will be asked about their nutritional intake during the timecourse of the assessments
Baseline, post 24 hours, and post 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Maia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2025

Primary Completion (Actual)

April 15, 2025

Study Completion (Actual)

July 12, 2025

Study Registration Dates

First Submitted

January 12, 2025

First Submitted That Met QC Criteria

February 3, 2025

First Posted (Actual)

February 7, 2025

Study Record Updates

Last Update Posted (Actual)

July 30, 2025

Last Update Submitted That Met QC Criteria

July 29, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PDFM_005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe